Agenus Company Profile (NASDAQ:AGEN)

About Agenus

Agenus logoAgenus Inc. (Agenus) is an immuno-oncology company. The Company is engaged in discovering and developing treatments for patients with cancer. Its approaches are driven by platforms and programs, which include antibody discovery platform, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage and AutoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company has a portfolio of programs in various stages of development, including a series of antibodies in discovery and pre-clinical and clinical development, Prophage vaccine, a Heat Shock Protein (HSP)-based vaccine candidate for a form of brain cancer that has completed Phase II trials, and a number of QS-21 Stimulon-containing vaccine candidates in late stage development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AGEN
  • CUSIP: 00847G70
Key Metrics:
  • Previous Close: $7.00
  • 50 Day Moving Average: $6.31
  • 200 Day Moving Average: $4.71
  • 52-Week Range: $2.61 - $7.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.61
  • P/E Growth: 0.00
  • Market Cap: $599.69M
  • Outstanding Shares: 86,912,000
  • Beta: 2.02
Profitability:
  • Net Margins: -328.53%
  • Return on Equity: -138.27%
  • Return on Assets: -32.03%
Debt:
  • Debt-to-Equity Ratio: 7.24%
  • Current Ratio: 4.12%
  • Quick Ratio: 4.11%
Additional Links:
Companies Related to Agenus:

Analyst Ratings

Consensus Ratings for Agenus (NASDAQ:AGEN) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.33 (64.25% upside)

Analysts' Ratings History for Agenus (NASDAQ:AGEN)
Show:
DateFirmActionRatingPrice TargetDetails
8/23/2016Jefferies GroupReiterated RatingBuyView Rating Details
7/31/2016HC WainwrightReiterated RatingBuy$10.00View Rating Details
7/28/2016Maxim GroupReiterated RatingBuy$7.00View Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details
12/31/2015Oppenheimer Holdings Inc.Reiterated RatingPositive -> Outperform$14.00View Rating Details
9/10/2015William BlairReiterated RatingBuyView Rating Details
7/27/2015MLV & Co.Reiterated RatingBuy$9.00 -> $11.00View Rating Details
(Data available from 9/24/2014 forward)

Earnings

Earnings History for Agenus (NASDAQ:AGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
7/28/2016Q216($0.34)($0.33)$5.12 million$6.59 millionViewListenView Earnings Details
4/28/2016Q116($0.23)($0.37)$5.16 millionViewListenView Earnings Details
3/3/2016Q415($0.17)($0.18)$9.39 million$7.64 millionViewListenView Earnings Details
10/27/2015Q315($0.15)($0.16)$7.56 millionViewListenView Earnings Details
7/23/2015Q215($0.15)($0.44)$5.71 million$6.38 millionViewListenView Earnings Details
4/23/2015Q115($0.01)($0.28)$11.66 million$3.95 millionViewN/AView Earnings Details
2/26/2015Q414($0.16)($0.41)$1.62 millionViewN/AView Earnings Details
10/31/2014Q314($0.15)($0.13)$1.96 million$1.56 millionViewN/AView Earnings Details
7/24/2014Q214($0.17)($0.12)$3.07 millionViewN/AView Earnings Details
5/8/2014Q114($0.13)($0.01)$0.55 million$0.72 millionViewN/AView Earnings Details
3/5/2014Q413($0.24)($0.16)$870.00 million$393.00 millionViewN/AView Earnings Details
10/24/2013Q313($0.27)($0.24)$736.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013($0.21)($0.40)ViewN/AView Earnings Details
2/28/2013Q4 2012($0.24)($0.23)$0.72 million$1.09 millionViewN/AView Earnings Details
7/28/2011($0.05)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Agenus (NASDAQ:AGEN)
Current Year EPS Consensus Estimate: $-1.32 EPS
Next Year EPS Consensus Estimate: $-1.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.18)($0.18)($0.18)
Q2 20161($0.39)($0.39)($0.39)
Q3 20161($0.44)($0.44)($0.44)
Q4 20161($0.47)($0.47)($0.47)
Q1 20171($0.24)($0.24)($0.24)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.25)($0.25)($0.25)
Q4 20171($0.25)($0.25)($0.25)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Agenus (NASDAQ:AGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Agenus (NASDAQ:AGEN)
Insider Ownership Percentage: 7.60%
Institutional Ownership Percentage: 40.63%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2016Ulf WiinbergDirectorBuy30,000$6.29$188,700.00View SEC Filing  
5/9/2016Garo H ArmenCEOBuy100,000$3.18$318,000.00View SEC Filing  
5/5/2016Ozer BaysalInsiderBuy2,250$3.10$6,975.00View SEC Filing  
3/7/2016Garo H ArmenCEOBuy200,000$4.03$806,000.00View SEC Filing  
12/29/2015Garo H. ArmenCEOSell219,576$4.59$1,007,853.84View SEC Filing  
12/28/2015Garo H. ArmenCEOSell134,352$4.60$618,019.20View SEC Filing  
9/25/2015Charles Evan BallantyneCFOBuy10,000$5.05$50,500.00View SEC Filing  
9/25/2015Garo H ArmenCEOBuy100,000$5.03$503,000.00View SEC Filing  
4/29/2015Shahzad MalikDirectorSell1,107,377$7.11$7,873,450.47View SEC Filing  
1/9/2015Qvt Associates Gp LlcMajor ShareholderSell2,343,630$5.31$12,444,675.30View SEC Filing  
1/23/2014Karen ValentineVPSell2,850$3.50$9,975.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Agenus (NASDAQ:AGEN)
DateHeadline
News IconUS Nasdaq-quoted business moves into Cambridge (NASDAQ:AGEN)
www.businessweekly.co.uk - September 23 at 3:48 PM
News IconAnalysts Valuations For Two Stocks: Agenus Inc (NASDAQ:AGEN ... - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 22 at 3:20 PM
thestreet.com logoInteresting AGEN Put And Call Options For May 2017 (NASDAQ:AGEN)
www.thestreet.com - September 21 at 4:01 PM
News IconAgenus Inc. (NASDAQ: AREX) stock reaches new 52-week high - BNB Daily (blog) (NASDAQ:AGEN)
www.baseball-news-blog.com - September 20 at 3:22 PM
News IconIntraday Active Biotech Stocks News: Medivation, Inc. (NASDAQ:MDVN), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 20 at 3:22 PM
News IconAgenus Inc. (NASDAQ:AGEN) topped earnings-per-share estimates 41% of the time - The Independent Republic (NASDAQ:AGEN)
theindependentrepublic.com - September 20 at 9:10 AM
prnewswire.com logoResearch Reports Initiation on Biotech Stocks -- Agenus, Nektar Therapeutics, GlobeImmune and Anthera Pharma - PR Newswire (press release) (NASDAQ:AGEN)
www.prnewswire.com - September 20 at 9:10 AM
News IconSteady Stock Movements: Agenus Inc. (NASDAQ:AGEN), Sunrun Inc ... - Newburgh Press (NASDAQ:AGEN)
newburghpress.com - September 19 at 4:16 PM
News IconNews review of 2 biotech stocks: Agenus Inc. (NASDAQ:AGEN ... - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 19 at 4:16 PM
News IconHC Stocks Assessment! Merrimack Pharmaceuticals Inc (MACK), Agenus Inc (NASDAQ:AGEN) - share market updates (press release) (NASDAQ:AGEN)
sharemarketupdates.com - September 19 at 8:08 AM
foxnews.com logoGSK shingles vaccine remains effective after four years: study (NASDAQ:AGEN)
www.foxnews.com - September 16 at 3:22 PM
News IconTrading the Biotech News: Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 15 at 12:14 PM
News IconToday Agenus Inc Stock Rises - Chester Independent - Chester News (NASDAQ:AGEN)
www.chesterindependent.com - September 15 at 12:14 PM
News Icon2 Biotech Stocks News And Price Trends: Agenus Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 12 at 3:22 PM
publicnow.com logoSep 6, 2016 (NASDAQ:AGEN)
www.publicnow.com - September 12 at 3:22 PM
fool.com logoAre These 3 Clinical-Stage Biotechs Still Buys After Soaring in August? (NASDAQ:AGEN)
www.fool.com - September 11 at 8:07 AM
News IconAgenus Inc. (NASDAQ:AGEN) Sale Analysis - Newburg Press (NASDAQ:AGEN)
newburghpress.com - September 8 at 11:54 AM
News IconActive biotech company shares in the news: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Agenus Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 8 at 11:54 AM
News IconActive biotech company shares in the news: Clovis Oncology (CLVS), Agenus (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 7 at 8:30 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Agenus Inc. (NASDAQ:AGEN) Stock - Frisco Fastball (NASDAQ:AGEN)
friscofastball.com - September 7 at 3:22 PM
prnewswire.com logoAgenus to Present at the Rodman & Renshaw 18th Annual Global Investment Conference - PR Newswire (press release) (NASDAQ:AGEN)
www.prnewswire.com - September 7 at 3:22 PM
News IconTrading the Biotech News: Cempra, Inc. (NASDAQ:CEMP), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 6 at 3:21 PM
News IconAgenus Inc. (NASDAQ:AGEN) Near to Lift Curtain on September 2016 Earnings - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - September 6 at 3:21 PM
finance.yahoo.com logoAgenus to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:AGEN)
finance.yahoo.com - September 6 at 3:21 PM
News IconBiotech news that matter for investors: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 31 at 3:21 PM
News IconTime To Put On The Watch List? - Agenus Inc. (NASDAQ:AGEN), Galena Biopharma, Inc. (NASDAQ:GALE) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 30 at 3:21 PM
News IconAgenus Inc. (NASDAQ:AGEN) earnings expectations - The Independent Republic (NASDAQ:AGEN)
theindependentrepublic.com - August 25 at 3:22 PM
News IconTop Earnings to Watch for: Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 25 at 3:22 PM
News IconGlobal vaccine adjuvants market research report - forecast to 2027 explored in latest research (NASDAQ:AGEN)
www.whatech.com - August 24 at 11:39 AM
capitalcube.com logoETF’s with exposure to Agenus, Inc. : August 23, 2016 (NASDAQ:AGEN)
www.capitalcube.com - August 23 at 3:20 PM
News Icon2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now (NASDAQ:AGEN)
www.biospace.com - August 20 at 8:14 AM
News IconSell-side is Weighing in on Agenus Inc. (NASDAQ:AGEN) Earnings - Post News (NASDAQ:AGEN)
www.kentuckypostnews.com - August 19 at 11:45 AM
fool.com logo2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now (NASDAQ:AGEN)
www.fool.com - August 18 at 11:41 AM
News IconNews review of 2 biotech stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 16 at 3:22 PM
News IconVaccine Adjuvants Market worth 769.4 Million USD by 2021 (NASDAQ:AGEN)
www.emailwire.com - August 15 at 10:37 AM
News IconHot Biotech Stocks Recap: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 12 at 3:32 PM
finance.yahoo.com logoAGENUS INC Financials (NASDAQ:AGEN)
finance.yahoo.com - August 12 at 3:32 PM
finance.yahoo.com logoWhy Agenus (AGEN) Stock Might be a Great Pick (NASDAQ:AGEN)
finance.yahoo.com - August 12 at 11:55 AM
feeds.benzinga.com logoWatch These 7 Huge Call Purchases In Friday Trade (NASDAQ:AGEN)
feeds.benzinga.com - August 12 at 2:53 AM
prnewswire.com logoResearch Report Initiation on Biotech Stocks -- Agenus, ProNAi Therapeutics, Vanda Pharma, and Genocea Biosciences (NASDAQ:AGEN)
www.prnewswire.com - August 11 at 12:34 PM
capitalcube.com logoETF’s with exposure to Agenus, Inc. : August 11, 2016 (NASDAQ:AGEN)
www.capitalcube.com - August 11 at 12:34 PM
capitalcube.com logoAgenus, Inc. :AGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:AGEN)
www.capitalcube.com - August 10 at 3:41 PM
fortune.com logoLooking At Recent Analyst Ratings: Eclipse Resources Corp (NYSE:ECR), Agenus Inc (NASDAQ:AGEN) - Review Fortune (NASDAQ:AGEN)
reviewfortune.com - August 9 at 3:59 PM
streetupdates.com logoUpdated Analysts Rating Report: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN)
www.streetupdates.com - August 8 at 8:09 AM
tradecalls.org logoJefferies Maintains Agenus Inc to Buy with Price Target $7.00 ... - Trade Calls (NASDAQ:AGEN)
www.tradecalls.org - August 8 at 8:09 AM
streetupdates.com logoTraders Focused Stocks: Agenus Inc. (NASDAQ:AGEN) , Edwards ... - Street Updates (NASDAQ:AGEN)
www.streetupdates.com - August 5 at 8:46 PM
equities.com logoAgenus Inc. (AGEN) Jumps 9.03% on August 05 - Equities.com (NASDAQ:AGEN)
www.equities.com - August 5 at 8:46 PM
News IconAgenus Inc (NASDAQ:AGEN): That’s How Our Members Are Already up 25% In 3-Week, Buy Call At $4.96 (NASDAQ:AGEN)
www.marketnewscall.com - August 5 at 3:22 PM
News IconDiscover the Global vaccine adjuvants market forecast to 2021 (NASDAQ:AGEN)
www.whatech.com - August 5 at 11:45 AM
News IconGlobal Vaccine Adjuvants Sales Market Report to 2021: Brenntag Biosector, Seppic, CSL Limited, Agenus Inc (NASDAQ:AGEN)
www.medgadget.com - August 5 at 11:45 AM

Social

Agenus (NASDAQ:AGEN) Chart for Saturday, September, 24, 2016


Last Updated on 9/24/2016 by MarketBeat.com Staff